Klerkx WM, Bax L, Veldhuis WB, Heintz AP, Mali WP, Peeters PH, Moons KG. 
Detection of lymph node metastases by gadolinium-enhanced magnetic resonance imaging: systematic review and meta-analysis. 
Journal of the National Cancer Institute 2010; 102(4): 244-253 DARE.

Lambin P, Ramaekers BLT, van Mastrigt GAPG, Van den Ende P, de Jong J, De Ruysscher DK M, Pijls-Johannesma M.
Erythropoietin as an adjuvant treatment with (chemo) radiation therapy for head and neck cancer.
Cochrane Database of Systematic Reviews 2009, Issue 3.
Eritropoyetina como tratamiento adyuvante con (quimio) radioterapia para el cáncer de cabeza y cuello (Revision Cochrane traducida). En: Biblioteca Cochrane Plus 2009 Número 3

Stableforth W D, Thomas S, Lewis S J.
A systematic review of the role of immunonutrition in patients undergoing surgery for head and neck cancer.
International Journal of Oral and Maxillofacial Surgery 2009; 38(2): 103-110.DARE

PET for Head and Neck Cancer . MSAC. 2009.

Detection of lymph node metastases in head and neck cancer: a meta-analysis comparing US, USgFNAC, CT and MR imaging. de Bondt R B, Nelemans P J, Hofman P A, Casselman J W, Kremer B, van Engelshoven J M, Beets-Tan R G European Journal of Radiology 2007; 64(2): 266-272. DARE.

Comparative Effectiveness and Safety of Radiotherapy Treatments for Head and Neck Cancer.  Effective Health Care. 2007.

Su Y X, Zheng J W, Zheng G S, Liao G Q, Zhang Z Y.  
Neoadjuvant chemotherapy of cisplatin and fluorouracil regimen in head and neck squamous cell carcinoma: a meta-analysis. 
Chinese Medical Journal 2008; 121(19): 1939-1944.DARE. Pubmed.

McNeely M L.  
Exercise rehabilitation for breast and head and neck cancer survivors. 
Edmonton, Alberta: University of Alberta. 2007.DARE.

Cetuximab (Erbitux) - Metastatic and/or recurrent squamous cell carcinoma of the head and neck (SCCHN). National Horizon Scanning Centre. 2006.

Radiotherapy for cancer. SBU. 2004.

Management of head and neck cancers. Centre for Reviews and Dissemination. Effective Health care. 2004.

Docetaxel in stage II, III or IV head and neck cancer. National Horizon Scanning Centre (NHSC), 2005:6. HTA.

Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data.   Pignon J P, Bourhis J, Domenge C, Designe L. Lancet. 2000;355:949-955. DARE.

Head and Neck Cancer. Moller T, for SBU, the Swedish Council on Technology Assessment in Health Care. Acta Oncologica 1996; 35(Supplement 7): 22-45. DARE.

Whole-grain intake and cancer: an expanded review and meta-analysis. Jacobs D R, Marquart L, Slavin J, Kushi L H. Nutrition and Cancer 1998; 30(2): 85-96. DARE

Hyperfractionated radiotherapy of human tumors: overview of the randomized clinical trials. Stuschke M, Thames H D. International Journal of Radiation Oncology, Biology, Physics 1997; 37(2): 259-267. DARE

Adjuvant and adjunctive chemotherapy in the management of squamous cell carcinoma of the head and neck region: a meta-analysis of prospective and randomized trials. El-Sayed S, Nelson N. Journal of Clinical Oncology 1996; 14(3): 838-847. DARE

Photodynamic Therapy for Head and Neck, Tracheobronchial, and Esophageal Cancer. Institute for Clinical Systems Improvement. 2002. HTA

Detection of cervical metastasis: a meta-analysis comparing computed tomography with physical examination. Merritt R M, Williams M F, James T H, Porubsky E S. Archives of Otolaryngology Head and Neck Surgery 1997; 123(2): 149-152. DARE

Perioperative blood transfusion and cancer recurrence: meta-analysis for explanation. Vamvakas E C. Transfusion 1995; 35(9): 760-768. DARE

Positron emission tomography: systematic review: PET as a diagnostic test in head and neck cancer. Flynn K. Boston, MA, USA: Veterans Affairs Medical Center, Health Services Research and Development Service, Management Decision and Research Center 1996: 1-18. DARE.

Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review. Trotti A, Bellm L A, Epstein J B, Frame D, Fuchs H J, Gwede C K, Komaroff E, Nalysnyk L, Zilberberg M D. Radiotherapy and Oncology. 2003;66(3):253-262. DARE

The effectiveness of strategies for preventing and treating chemotherapy and radiation induced oral mucositis in patients with cancer.  Kowanko I, Long L, Hodgkinson B, Evans D. Adelaide, S. Australia, Australia: Joanna Briggs Institute for Evidence Based Nursing and Midwifery 1998: 1-84. DARE

Pilocarpine for radiation-induced xerostomia in head and neck cancer. Hawthorne M, Sullivan K. International Journal of Palliative Nursing 2000; 6(5): 228, 230-232. DARE.

Prophylaxis of oral mucositis in irradiated head-and-neck cancer patients: a proposed classification scheme of interventions and meta-analysis of randomized controlled trials. Sutherland S E, Browman G P. International Journal of Radiation Oncology, Biology, Physics 2001; 49(4): 917-930. DARE

The Prevention and Treatment of Oral Mucositis in Cancer Patients . Best Practice.1998.

Excision of head and neck basal cell carcinoma with a rapid, cross-sectional, frozen-section technique. Bentkover S H, Grande D M, Soto H, Kozlicak B A, Guillaume D, Girouard S. Archives of Facial Plastic Surgery, 2002;4(2):114-119. NHS EED

Clinical care pathway for head and neck cancer: a valuable tool for decreasing resource utilization. Gendron K M, Lai S Y, Weinstein G S, Chalian A A, Husbands J M, Wolf P F, DiDonato L, Weber R S. Archives of Otolaryngology, Head & Neck Surgery, 2002;128(3):258-262. NHS EED

The cost-effectiveness of fluorodeoxyglucose 18-F positron emission tomography in the NO neck. Hollenbeak C S, Lowe V J, Stack B C. Cancer, 2001;92(9):2341-2348. NHS EED.

Feasibility and cost-effectiveness of sentinel lymph node radiolocalization in stage NO head and neck cancer. Kosuda S, Kusano S, Kohno N, Ohno Y, Tanabe T, Kitahara S, Tamai S. Archives of Otolaryngology - Head & Neck Surgery, 2003;129(10):1105-1109. NHS EED